Lab tests show molecule appears to spur cell death in tumors, inflammation
Thursday, August 17, 2017 - 12:32
in Health & Medicine
A drug-like molecule developed by Duke Health researchers appears to intercede in an inflammatory response that is at the center of a variety of diseases, including some cancers, rheumatoid arthritis and Crohn's disease.